Most individuals with Rett syndrome carry mutations in the X-linked gene that codes for methyl-CpG-binding protein 2 (MeCP2), an important regulator of gene expression and the loss of which is associated with reduced production of another protein, brain-derived neurotrophic factor (BDNF). This evidence concerns the gene MECP2 and atypical Rett syndrome.